Cervical cancer screening and updated Pap guidelines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19231606.
- Also identified by DOI 10.1016/j.pop.2008.10.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanicolaou testing is critical, and interpretation of test results with knowledge of patient risk factors is imperative. Many evidence-based guidelines for screening, interpretation, and management have been developed and are widely available for use.
Medical subject headings
- Mass Screening
- Papanicolaou Test
- Practice Guidelines as Topic
- Uterine Cervical Neoplasms
- Vaginal Smears
- Women's Health
- Uterine Cervical Dysplasia